Bincike na tsawon shekaru biyu da aka wallafa a JAMA Cardiology ya gano cewa shan 360 µg na kowace rana na bitamin K2 (menaquinone‑7) yana rage saurin ƙara calcium a jijiyoyin zuciya ga masu cutar CAD. A rukuni da aka ba da MK‑7, ƙimar CAC ta tashi daga 135 zuwa 184 AU, yayin da a rukuni placebo ta tashi daga 145 zuwa 214 AU. Binciken ya nuna cewa tasirin yana da alaƙa da rage canjin plaques marasa calcium zuwa waɗanda suke ɗan samun calcium. Babu wani mummunan sakamako da aka lura, amma har yanzu ba a san ko hakan zai rage yiwuwar bugun zuciya ba, kuma wasu marubuta sun bayyana karɓar tallafi daga kamfanin da ke kera MK‑7.
This page is available in